Biomaterials Access Assurance Act of 1998

Last updated
Biomaterials Access Assurance Act of 1998
Great Seal of the United States (obverse).svg
Long titleAn Act to establish rules governing product liability actions against raw materials and bulk component suppliers to medical device manufacturers, and for other purposes.
NicknamesBiomaterials Access Assurance Act of 1997
Enacted bythe 105th United States Congress
EffectiveAugust 13, 1998
Citations
Public law 105–230
Statutes at Large 112  Stat.   1519
Codification
Titles amended 21 U.S.C.: Food and Drugs
U.S.C. sections created 21 U.S.C. ch. 21 § 1601 et seq.
Agencies affected Food and Drug Administration
Legislative history
  • Introduced in the House as H.R. 872 by George Gekas (RPA) on February 27, 1997
  • Committee consideration by House Judiciary, House Commerce
  • Passed the House on July 30, 1998 (Passed without objection)
  • Passed the Senate on July 30, 1998 (Passed unanimous consent)
  • Signed into law by President William J. Clinton on August 13, 1998

Biomaterials Access Assurance Act of 1998 is a United States federal statute establishing liability exemptions for biomaterial suppliers selling chemical components and raw materials utilized in implantable devices for human recipients. The United States federal legislation sets forth rules limiting litigation costs or unwarranted lawsuits for biomaterial suppliers excluded from the design, production, and testing of implantable devices demonstrated as effective and safe to include adequate product warnings.

Contents

The H.R. 872 bill was passed by the 105th United States Congressional session and enacted into law by the 42nd President of the United States Bill Clinton on August 13, 1998. [1]

Provision of the Act

The 1998 Act was compiled as six sections establishing liability rulings for biomaterial elements sold by domestic and international suppliers to healthcare manufacturers located in the continental United States.

21 U.S.C. § 1601 ~ U.S. Congressional findings
21 U.S.C. § 1602 ~ Definitions
21 U.S.C. § 1603 ~ General requirements, applicability, and preemption
21 U.S.C. § 1604 ~ Liability of biomaterials suppliers
21 U.S.C. § 1605 ~ Procedures for dismissal of civil actions against biomaterials suppliers
21 U.S.C. § 1606 ~ Subsequent impleader of dismissed biomaterials supplier

Legislation of 1995

On January 31, 1995, the 104th United States House of Representatives and United States Senate introduced the initial liability exemption legislation for suppliers dealing in biomaterial bulk products. [2] [3]

See also

Biocompatibility
Biomaterial Surface Modifications
Biopolymer
Mechanical properties of biomaterials
Medical Device Regulation Act
Surface modification of biomaterials with proteins

Related Research Articles

<span class="mw-page-title-main">Gramm–Leach–Bliley Act</span> Act of the 106th United States Congress (1999–2001)

The Gramm–Leach–Bliley Act (GLBA), also known as the Financial Services Modernization Act of 1999, is an act of the 106th United States Congress (1999–2001). It repealed part of the Glass–Steagall Act of 1933, removing barriers in the market among banking companies, securities companies, and insurance companies that prohibited any one institution from acting as any combination of an investment bank, a commercial bank, and an insurance company. With the passage of the Gramm–Leach–Bliley Act, commercial banks, investment banks, securities firms, and insurance companies were allowed to consolidate. Furthermore, it failed to give to the SEC or any other financial regulatory agency the authority to regulate large investment bank holding companies. The legislation was signed into law by President Bill Clinton.

The Contract with America was a legislative agenda advocated by the Republican Party during the 1994 congressional election campaign. Written by Newt Gingrich and Dick Armey, and in part using text from former President Ronald Reagan's 1985 State of the Union Address, the Contract detailed the actions the Republicans promised to take if they became the majority party in the United States House of Representatives for the first time in 40 years. Many of the Contract's policy ideas originated at The Heritage Foundation, a conservative think tank.

<span class="mw-page-title-main">Commodity Futures Modernization Act of 2000</span> United States federal legislation

The Commodity Futures Modernization Act of 2000 (CFMA) is United States federal legislation that ensured financial products known as over-the-counter (OTC) derivatives remained unregulated. It was signed into law on December 21, 2000 by President Bill Clinton. It clarified the law so most OTC derivative transactions between "sophisticated parties" would not be regulated as "futures" under the Commodity Exchange Act of 1936 (CEA) or as "securities" under the federal securities laws. Instead, the major dealers of those products would continue to have their dealings in OTC derivatives supervised by their federal regulators under general "safety and soundness" standards. The Commodity Futures Trading Commission's (CFTC) desire to have "functional regulation" of the market was also rejected. Instead, the CFTC would continue to do "entity-based supervision of OTC derivatives dealers". The CFMA's treatment of OTC derivatives such as credit default swaps has become controversial, as those derivatives played a major role in the financial crisis of 2008 and the subsequent 2008–2012 global recession.

The Employment Non-Discrimination Act (ENDA) is legislation proposed in the United States Congress that would prohibit discrimination in hiring and employment on the basis of sexual orientation or, depending on the version of the bill, gender identity, by employers with at least 15 employees.

<span class="mw-page-title-main">Freedom of Information Act (United States)</span> 1967 US statute regarding access to information held by the US government

The Freedom of Information Act, 5 U.S.C. § 552, is the United States federal freedom of information law that requires the full or partial disclosure of previously unreleased or uncirculated information and documents controlled by the U.S. government upon request. The act defines agency records subject to disclosure, outlines mandatory disclosure procedures, and includes nine exemptions that define categories of information not subject to disclosure. The act was intended to make U.S. government agencies' functions more transparent so that the American public could more easily identify problems in government functioning and put pressure on Congress, agency officials, and the president to address them. The FOIA has been changed repeatedly by both the legislative and executive branches.

<span class="mw-page-title-main">Iraq Liberation Act</span>

The Iraq Liberation Act of 1998 is a United States Congressional statement of policy stating that "It should be the policy of the United States to support efforts to remove the regime headed by Saddam Hussein from power in Iraq." It was signed into law by President Bill Clinton, and states that it is the policy of the United States to support democratic movements within Iraq. The Act was cited in October 2002 to argue for the authorization of military force against Iraq.

<span class="mw-page-title-main">Equal Pay Act of 1963</span> United States labor law of the New Frontier program

The Equal Pay Act of 1963 is a United States labor law amending the Fair Labor Standards Act, aimed at abolishing wage disparity based on sex. It was signed into law on June 10, 1963, by John F. Kennedy as part of his New Frontier Program. In passing the bill, Congress stated that sex discrimination:

<span class="mw-page-title-main">Taxpayer Relief Act of 1997</span> United States tax cut law

The Taxpayer Relief Act of 1997 was enacted by the 105th United States Congress and signed into law by President Bill Clinton. The legislation reduced several federal taxes in the United States and notably created the Roth IRA.

The Berry Amendment, requires the Department of Defense (DOD) to give preference in procurement to domestically produced, manufactured, or home-grown products, most notably food, clothing, fabrics, and specialty metals. Congress originally passed domestic source restrictions as part of the 1941 Fifth Supplemental DOD Appropriations Act in order to protect the domestic industrial base in the time of war.

<span class="mw-page-title-main">Uruguay Round Agreements Act</span> US free trade law with implications for intellectual property

The Uruguay Round Agreements Act is an Act of Congress in the United States that implemented in U.S. law the Marrakesh Agreement of 1994. The Marrakesh Agreement was part of the Uruguay Round of negotiations which transformed the General Agreement on Tariffs and Trade (GATT) into the World Trade Organization (WTO). One of its effects is to give United States copyright protection to foreign works that had previously been in the public domain in the United States.

<span class="mw-page-title-main">William J. Hughes</span> American politician (1932–2019)

William John "Jack" Hughes was an American politician and diplomat who served as a Democratic member of the U.S. House of Representatives from 1975 to 1995, representing New Jersey's Second Congressional District which includes major portions of the Jersey Shore and Pine Barrens, the cities of Vineland and Atlantic City, and the counties of Salem, Cumberland, Atlantic, Cape May and part of Gloucester. After retiring from Congress in 1995, Hughes was appointed by President Bill Clinton as United States Ambassador to Panama, a post he held until October, 1998 leading up to the historic turnover of the Panama Canal to Panamanian control.

<span class="mw-page-title-main">Public Readiness and Emergency Preparedness Act</span> US law

The Public Readiness and Emergency Preparedness Act (PREPA), passed by the United States Congress and signed into law by President of the United States George W. Bush in December 2005, is a controversial tort liability shield intended to protect pharmaceutical manufacturers from financial risk in the event of a declared public health emergency. The part of PREPA that actually affords such protection is now codified at 42 U.S.C. § 247d-6d. The act specifically affords to drug makers immunity from actions related to the manufacture, testing, development, distribution, administration and use of medical countermeasures against chemical, biological, radiological and nuclear agents of terrorism, epidemics, and pandemics. PREPA strengthens and consolidates the oversight of litigation against pharmaceutical companies under the purview of the secretary of Health and Human Services (HHS). PREPA provides $3.8 billion for pandemic influenza preparedness to protect public health in the case of a pandemic disease outbreak.

<span class="mw-page-title-main">Digital Millennium Copyright Act</span> United States copyright law

The Digital Millennium Copyright Act (DMCA) is a 1998 United States copyright law that implements two 1996 treaties of the World Intellectual Property Organization (WIPO). It criminalizes production and dissemination of technology, devices, or services intended to circumvent measures that control access to copyrighted works. It also criminalizes the act of circumventing an access control, whether or not there is actual infringement of copyright itself. In addition, the DMCA heightens the penalties for copyright infringement on the Internet. Passed on October 12, 1998, by a unanimous vote in the United States Senate and signed into law by President Bill Clinton on October 28, 1998, the DMCA amended Title 17 of the United States Code to extend the reach of copyright, while limiting the liability of the providers of online services for copyright infringement by their users.

<span class="mw-page-title-main">Food and Drug Administration Modernization Act of 1997</span> US law

The United States Food and Drug Administration Modernization Act of 1997 (FDAMA) amended the Federal Food, Drug, and Cosmetic Act. This act is related to the regulation of food, drugs, devices, and biological products by the FDA. These changes were made in order to recognize the changes in the way the FDA would be operating in the 21st century. The main focus of this is the acknowledgment in the advancement of technological, trade, and public health complexities.

The self-executing rule, also known as "deem and pass" is a resolution that a bill be deemed to have pass ; if the resolution passes, the bill is automatically deemed to have passed with the amendment set forth in the resolution itself. This procedural measure has been used used by the United States Congress to approve a legislative rule that contains such a provision, the House of Representatives then deems a second piece of legislation as approved without requiring a separate vote, as long as it is specified in the rule. That is, if the vote on the rule passes, then the second piece of legislation is passed as part of the rule vote.

<span class="mw-page-title-main">H.R. 1961 (113th Congress)</span>

The bill H.R. 1961, entitled "to amend title 46, United States Code, to extend the exemption from the fire-retardant materials construction requirement for vessels operating within the Boundary Line," was legislation that was introduced into the United States House of Representatives during the 113th United States Congress.

<span class="mw-page-title-main">Foreign Narcotics Kingpin Designation Act</span> US anti-trafficking act

The Foreign Narcotics Kingpin Designation Act, better known as the Kingpin Act, is landmark federal legislation in the United States intended to address international narcotics trafficking by imposing United States sanctions on foreign persons and entities involved in the drug trade.

<span class="mw-page-title-main">Commercial Space Launch Act of 1984</span> Federal law facilitating commercialization of space technology

Commercial Space Launch Act of 1984 is a United States federal law authored to facilitate the private enterprise of the commercialization of space and space technology. The Act of Congress set forth the quest to acquire innovative equipment and services offered by entrepreneurial ventures from the information technology services, remote sensing technology, and telecommunications industries. The Act recognized the United States private sector as having the capability to develop commercial launch vehicles, orbital satellites, and operate private launch sites and services. The Act also assigned the duties of overseeing and coordinating commercial launches, issuing of licenses and permits, and promotion of safety standards to the Secretary of Department of Transportation.

<span class="mw-page-title-main">Unlocking Consumer Choice and Wireless Competition Act</span>

The Unlocking Consumer Choice and Wireless Competition Act is a United States public law that repeals a rulemaking determination by the United States Copyright Office that left it illegal for people to unlock their cellphones.

<span class="mw-page-title-main">Abandoned Barge Act of 1992</span>

Abandoned Barge Act of 1992, known as the Oceans Act of 1992, is United States federal law prohibiting the abandonment of barges in navigable and territorial waters. The Act of Congress establishes financial penalties and removal procedures for unattended barges exceeding forty-five days. The federal statute provides the U.S. Secretary of Transportation authority to contract with barge removal contractors for abandoned barges of more than one hundred gross tons.

References

  1. Peters, Gerhard; Woolley, John T. "William J. Clinton: "Statement on Signing the Biomaterials Access Assurance Act of 1998," August 13, 1998". The American Presidency Project. University of California - Santa Barbara. Archived from the original on September 16, 2016. Retrieved September 5, 2016.
  2. "H.R. 753 ~ Biomaterials Access Assurance Act of 1995". Congress.gov. January 31, 1995.
  3. "S. 303 ~ Biomaterials Access Assurance Act of 1995". Congress.gov. January 31, 1995.